Company Search:
Advanced Search
Sponsored Links
BioSino Bio-technology and Science Inc Company Snapshot
BioSino Bio-technology and Science Inc operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares BioSino Bio-technology and Science Inc with three other companies in this sector in China: Guangdong Hybribio Biotech Co Ltd (2016 sales of 398.30 million Chinese Renmimbi [US$62.87 million] ), Getein Biotech Inc (369.09 million Chinese Renmimbi [US$58.26 million] ), and Tellgen Corp (231.22 million Chinese Renmimbi [US$36.50 million] of which 92% was Reagent Income).

Sales Analysis. BioSino Bio-technology and Science Inc reported sales of 325.39 million Chinese Renmimbi (US$51.36 million) for the year ending December of 2016. This represents an increase of 12.1% versus 2015, when the company's sales were 290.38 million Chinese Renmimbi. Sales at BioSino Bio-technology and Science Inc have increased during each of the previous five years (and since 2011, sales have increased a total of 77%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
BioSino Bio-technology and Science Inc
  Stock Performance Chart for BioSino Bio-technology and Science Inc
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 1.82
(Figures in Chinese Renmimbi)
1 Week 9.6%   13 Weeks 9.1%  
4 Weeks 3.7%   52 Weeks -28.4%  
BioSino Bio-technology and Science Inc Key Data:
  Ticker: 8247 Country: China
  Exchanges: HKG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2016 Sales 325,388,000
(Year Ending Jan 2017).
Employees: 650
  Currency: Chinese Renmimbi Market Cap: 262,789,679
  Fiscal Yr Ends: December Shares Outstanding: 144,707,176
  Share Type: H Gu Closely Held Shares: 118,257,176
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.